Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133962) titled 'A Prospective, Single-Arm, Multicenter, Exploratory Clinical Study of Iodine125 Seed Implantation Combined with AipaluoliTuoworuilidan (a Novel Bispecific Antibody) and AG Regimen for Locally Advanced Pancreatic Cancer' on Oct. 9.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University)

Condition: Locally advanced pancreatic cancer.

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-10-15

Target Sample Size: Experimental group:47;

Countries of Recruitment: China

To k...